Pharmacological disruption of the Notch transcription factor complex
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological disruption of the Notch transcription factor complex
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume -, Issue -, Pages 201922606
Publisher
Proceedings of the National Academy of Sciences
Online
2020-06-30
DOI
10.1073/pnas.1922606117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Paeonol reverses promoting effect of the HOTAIR/miR-124/Notch1 axis on renal interstitial fibrosis in a rat model
- (2019) Hao Zhou et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition
- (2019) Roger A. Habets et al. Science Translational Medicine
- Disruption of NOTCH signaling by a small molecule inhibitor of the transcription factor RBPJ
- (2019) Cecilia Hurtado et al. Scientific Reports
- A randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer
- (2019) Zishuo Ian Hu et al. Cancer Medicine
- Notch1 signalling pathway promotes proliferation and mediates differentiation direction in hippocampus of Streptococcus pneumonia meningitis rats
- (2019) Zhijie Zhang et al. JOURNAL OF INFECTIOUS DISEASES
- A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours
- (2018) Kyaw L. Aung et al. INVESTIGATIONAL NEW DRUGS
- NOTCH1 Aberrations in Chronic Lymphocytic Leukemia
- (2018) Emanuela Rosati et al. Frontiers in Oncology
- First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer
- (2018) C Massard et al. ANNALS OF ONCOLOGY
- The Many Substrates of Presenilin/γ-Secretase
- (2018) Annakaisa Haapasalo et al. JOURNAL OF ALZHEIMERS DISEASE
- A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors
- (2018) David C. Smith et al. INVESTIGATIONAL NEW DRUGS
- Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors
- (2017) Renata Ferrarotto et al. JOURNAL OF CLINICAL ONCOLOGY
- Notch Signaling in Development, Tissue Homeostasis, and Disease
- (2017) Chris Siebel et al. PHYSIOLOGICAL REVIEWS
- The Small Molecule IMR-1 Inhibits the Notch Transcriptional Activation Complex to Suppress Tumorigenesis
- (2016) L. Astudillo et al. CANCER RESEARCH
- Targeting Notch Signaling with a Notch2/Notch3 Antagonist (Tarextumab) Inhibits Tumor Growth and Decreases Tumor-Initiating Cell Frequency
- (2015) W.-C. Yen et al. CLINICAL CANCER RESEARCH
- A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma
- (2015) C Papayannidis et al. Blood Cancer Journal
- DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice
- (2014) Sonia Minuzzo et al. CARCINOGENESIS
- A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia
- (2014) Daniel Herranz et al. NATURE MEDICINE
- Therapeutic modulation of Notch signalling — are we there yet?
- (2014) Emma R. Andersson et al. NATURE REVIEWS DRUG DISCOVERY
- Notch-1 Signaling Promotes the Malignant Features of Human Breast Cancer through NF-κB Activation
- (2014) Li Li et al. PLoS One
- Long-range enhancer activity determinesMycsensitivity to Notch inhibitors in T cell leukemia
- (2014) Yumi Yashiro-Ohtani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of Biomarkers Predictive of GSI Response in Triple-Negative Breast Cancer and Adenoid Cystic Carcinoma
- (2014) A. Stoeck et al. Cancer Discovery
- Notch controls retinal blood vessel maturation and quiescence
- (2013) M. Ehling et al. DEVELOPMENT
- Novel MIR143-NOTCH fusions in benign and malignant glomus tumors
- (2013) Juan-Miguel Mosquera et al. GENES CHROMOSOMES & CANCER
- NOTCH1-RBPJ complexes drive target gene expression through dynamic interactions with superenhancers
- (2013) H. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of Hes genes in intestinal development, homeostasis and tumor formation
- (2012) T. Ueo et al. DEVELOPMENT
- Whole-genome sequencing identifies recurrent somaticNOTCH2mutations in splenic marginal zone lymphoma
- (2012) Mark J. Kiel et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Using transcriptome sequencing to identify mechanisms of drug action and resistance
- (2012) Sarah A Wacker et al. Nature Chemical Biology
- Conformational Locking upon Cooperative Assembly of Notch Transcription Complexes
- (2012) Sung Hee Choi et al. STRUCTURE
- Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma
- (2011) R. Kridel et al. BLOOD
- Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
- (2011) D. Chen et al. CURRENT CANCER DRUG TARGETS
- Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells
- (2011) K. L. VanDussen et al. DEVELOPMENT
- Dll1- and Dll4-Mediated Notch Signaling Are Required for Homeostasis of Intestinal Stem Cells
- (2011) Luca Pellegrinet et al. GASTROENTEROLOGY
- Notch2 Receptor Signaling Controls Functional Differentiation of Dendritic Cells in the Spleen and Intestine
- (2011) Kanako L. Lewis et al. IMMUNITY
- Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer
- (2011) Dan R Robinson et al. NATURE MEDICINE
- Notch dimerization is required for leukemogenesis and T-cell development
- (2010) H. Liu et al. GENES & DEVELOPMENT
- Therapeutic antibody targeting of individual Notch receptors
- (2010) Yan Wu et al. NATURE
- Structural and mechanistic insights into cooperative assembly of dimeric Notch transcription complexes
- (2010) Kelly L Arnett et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Intestinal stem cells lacking the Math1 tumour suppressor are refractory to Notch inhibitors
- (2010) Johan H. van Es et al. Nature Communications
- Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer
- (2009) Brenda Cohen et al. BREAST CANCER RESEARCH AND TREATMENT
- The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
- (2009) Raphael Kopan et al. CELL
- Direct inhibition of the NOTCH transcription factor complex
- (2009) Raymond E. Moellering et al. NATURE
- Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27Kip1 and p57Kip2
- (2008) Orbicia Riccio et al. EMBO REPORTS
- Modulation of Notch Signaling by Antibodies Specific for the Extracellular Negative Regulatory Region of NOTCH3
- (2008) Kang Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started